Publications by authors named "Alexa Jordan"

Claim this Profile
T
The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma.
Vivian Jiang, William Lee, Tianci Zhang, Alexa Jordan, Fangfang Yan

Biomark Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma.
Fangfang Yan, Vivian Jiang, Alexa Jordan, Yuxuan Che, Yang Liu

Exp Hematol Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins.
Yijing Li, Heng-Huan Lee, Vivian Changying Jiang, Yuxuan Che, Joseph McIntosh, Alexa Jordan

Cell Death Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma.
Yuxuan Che, Yang Liu, Yijing Li, Joseph M McIntosh, Alexa Jordan

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma.
Lingzhi Li, Lei Nie, Alexa Jordan, Qingsong Cai, Yang Liu

Haematologica· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma.
Yang Liu, Fangfang Yan, Vivian Changying Jiang, Yijing Li, Yuxuan Che, Alexa Jordan

Haematologica· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma.
Vivian Changying Jiang, Yang Liu, Junwei Lian, Shengjian Huang, Alexa Jordan

J Clin Invest· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma.
Vivian Changying Jiang, Yang Liu, Alexa Jordan, Angela Leeming, Joseph McIntosh

J Hematol Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma.
Vivian Changying Jiang, Yang Liu, Alexa Jordan, Joseph McIntosh, Yijing Li

J Hematol Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis